The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform
Sharon Elad - One of the best experts on this subject based on the ideXlab platform.
-
basic Oral Care for hematology oncology patients and hematopoietic stem cell transplantation recipients a position paper from the joint task force of the multinational association of supportive Care in cancer international society of Oral oncology ma
Supportive Care in Cancer, 2015Co-Authors: Sharon Elad, Michael T Brennan, Judith E Raberdurlacher, Deborah P Saunders, Arno Mank, Yehuda Zadik, Barry Quinn, Joel B EpsteinAbstract:Hematology–oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for Oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic Oral Care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the Oral complications, expert opinion is needed to shape the current optimal protocols. This position paper was developed by members of the Oral Care Study Group, Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT) in attempt to provide guidance to the health Care providers managing these patient populations. The protocol on basic Oral Care outlined in this position paper is presented based on the following principles: prevention of infections, pain control, maintaining Oral function, the interplay with managing Oral complications of cancer treatment and improving quality of life. Using these fundamental elements, we developed a protocol to assist the health Care provider and present a practical approach for basic Oral Care. Research is warranted to provide robust scientific evidence and to enhance this clinical protocol.
-
basic Oral Care for hematology oncology patients and hematopoietic stem cell transplantation recipients a position paper from the joint task force of the multinational association of supportive Care in cancer international society of Oral oncology ma
Supportive Care in Cancer, 2015Co-Authors: Sharon Elad, Michael T Brennan, Judith E Raberdurlacher, Deborah P Saunders, Arno Mank, Yehuda Zadik, Barry Quinn, Joel B Epstein, N M A BlijlevensAbstract:Purpose Hematology–oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for Oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic Oral Care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the Oral complications, expert opinion is needed to shape the current optimal protocols.
-
systematic review of basic Oral Care for the management of Oral mucositis in cancer patients
Supportive Care in Cancer, 2013Co-Authors: Deborah B Mcguire, Janet S Fulton, Jumin Park, Carlton G Brown, Elvira M P Correa, June G Eilers, Sharon Elad, Faith Gibson, Loree Oberleedwards, Joanne M BowenAbstract:The purpose of this project was to evaluate research in basic Oral Care interventions to update evidence-based practice guidelines for preventing and treating Oral mucositis (OM) in cancer patients undergoing radio- or chemotherapy. A systematic review of available literature was conducted by the Basic Oral Care Section of the Mucositis Study Group of MASCC/ISOO. Seven interventions—Oral Care protocols, dental Care, normal saline, sodium bicarbonate, mixed medication mouthwash, chlorhexidine, and calcium phosphate—were evaluated using the Hadorn (J Clin Epidemiol 49:749–754, 1996) criteria to determine level of evidence, followed by a guideline determination of one of the following: recommendation, suggestion, or no guideline possible, using Somerfield’s (Classic Pap Cur Comments 4:881–886, 2000) schema. Fifty-two published papers were examined by treatment population (radiotherapy, chemotherapy, and hematopoietic stem cell transplant) and by whether the intervention aimed to prevent or treat OM. The resulting practice suggestions included using Oral Care protocols for preventing OM across all treatment modalities and age groups and not using chlorhexidine mouthwash for preventing OM in adults with head and neck cancer undergoing radiotherapy. Considering inadequate and/or conflicting evidence, no guidelines for prevention or treatment of OM were possible for the interventions of dental Care, normal saline, sodium bicarbonate, mixed medication mouthwash, chlorhexidine in patients receiving chemotherapy or hematopoietic stem cell transplant, or calcium phosphate. The evidence for basic Oral Care interventions supports the use of Oral Care protocols in patient populations receiving radiation and/or chemotherapy and does not support chlorhexidine for prevention of mucositis in head and neck cancer patients receiving radiotherapy. Additional well-designed research is needed for other interventions to improve the amount and quality of evidence guiding future clinical Care.
-
systematic review of basic Oral Care for the management of Oral mucositis in cancer patients
Supportive Care in Cancer, 2013Co-Authors: Deborah B Mcguire, Janet S Fulton, Jumin Park, Carlton G Brown, Elvira M P Correa, June G Eilers, Sharon Elad, Faith Gibson, Loree Oberleedwards, Joanne M BowenAbstract:Purpose The purpose of this project was to evaluate research in basic Oral Care interventions to update evidence-based practice guidelines for preventing and treating Oral mucositis (OM) in cancer patients undergoing radio- or chemotherapy.
Joel B Epstein - One of the best experts on this subject based on the ideXlab platform.
-
basic Oral Care for hematology oncology patients and hematopoietic stem cell transplantation recipients a position paper from the joint task force of the multinational association of supportive Care in cancer international society of Oral oncology ma
Supportive Care in Cancer, 2015Co-Authors: Sharon Elad, Michael T Brennan, Judith E Raberdurlacher, Deborah P Saunders, Arno Mank, Yehuda Zadik, Barry Quinn, Joel B EpsteinAbstract:Hematology–oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for Oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic Oral Care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the Oral complications, expert opinion is needed to shape the current optimal protocols. This position paper was developed by members of the Oral Care Study Group, Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT) in attempt to provide guidance to the health Care providers managing these patient populations. The protocol on basic Oral Care outlined in this position paper is presented based on the following principles: prevention of infections, pain control, maintaining Oral function, the interplay with managing Oral complications of cancer treatment and improving quality of life. Using these fundamental elements, we developed a protocol to assist the health Care provider and present a practical approach for basic Oral Care. Research is warranted to provide robust scientific evidence and to enhance this clinical protocol.
-
basic Oral Care for hematology oncology patients and hematopoietic stem cell transplantation recipients a position paper from the joint task force of the multinational association of supportive Care in cancer international society of Oral oncology ma
Supportive Care in Cancer, 2015Co-Authors: Sharon Elad, Michael T Brennan, Judith E Raberdurlacher, Deborah P Saunders, Arno Mank, Yehuda Zadik, Barry Quinn, Joel B Epstein, N M A BlijlevensAbstract:Purpose Hematology–oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for Oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic Oral Care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the Oral complications, expert opinion is needed to shape the current optimal protocols.
Michael T Brennan - One of the best experts on this subject based on the ideXlab platform.
-
basic Oral Care for hematology oncology patients and hematopoietic stem cell transplantation recipients a position paper from the joint task force of the multinational association of supportive Care in cancer international society of Oral oncology ma
Supportive Care in Cancer, 2015Co-Authors: Sharon Elad, Michael T Brennan, Judith E Raberdurlacher, Deborah P Saunders, Arno Mank, Yehuda Zadik, Barry Quinn, Joel B Epstein, N M A BlijlevensAbstract:Purpose Hematology–oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for Oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic Oral Care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the Oral complications, expert opinion is needed to shape the current optimal protocols.
-
basic Oral Care for hematology oncology patients and hematopoietic stem cell transplantation recipients a position paper from the joint task force of the multinational association of supportive Care in cancer international society of Oral oncology ma
Supportive Care in Cancer, 2015Co-Authors: Sharon Elad, Michael T Brennan, Judith E Raberdurlacher, Deborah P Saunders, Arno Mank, Yehuda Zadik, Barry Quinn, Joel B EpsteinAbstract:Hematology–oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for Oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic Oral Care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the Oral complications, expert opinion is needed to shape the current optimal protocols. This position paper was developed by members of the Oral Care Study Group, Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT) in attempt to provide guidance to the health Care providers managing these patient populations. The protocol on basic Oral Care outlined in this position paper is presented based on the following principles: prevention of infections, pain control, maintaining Oral function, the interplay with managing Oral complications of cancer treatment and improving quality of life. Using these fundamental elements, we developed a protocol to assist the health Care provider and present a practical approach for basic Oral Care. Research is warranted to provide robust scientific evidence and to enhance this clinical protocol.
-
systematic reviews of Oral complications from cancer therapies Oral Care study group mascc isoo methodology and quality of the literature
Supportive Care in Cancer, 2010Co-Authors: Michael T Brennan, Linda S. Elting, Fred K L SpijkervetAbstract:Background Oral complications are commonly experienced by patients undergoing cancer therapies. The Oral Care Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) has completed nine systematic reviews including Bisphosphonate Osteonecrosis of the Jaw, Odontogenic/Periodontal Infection, Dysgeusia, Oral Fungal Infection, Osteoradionecrosis, Trismus, Oral Pain, Oral Viral Infection, and Xerostomia.
Yehuda Zadik - One of the best experts on this subject based on the ideXlab platform.
-
basic Oral Care for hematology oncology patients and hematopoietic stem cell transplantation recipients a position paper from the joint task force of the multinational association of supportive Care in cancer international society of Oral oncology ma
Supportive Care in Cancer, 2015Co-Authors: Sharon Elad, Michael T Brennan, Judith E Raberdurlacher, Deborah P Saunders, Arno Mank, Yehuda Zadik, Barry Quinn, Joel B EpsteinAbstract:Hematology–oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for Oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic Oral Care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the Oral complications, expert opinion is needed to shape the current optimal protocols. This position paper was developed by members of the Oral Care Study Group, Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT) in attempt to provide guidance to the health Care providers managing these patient populations. The protocol on basic Oral Care outlined in this position paper is presented based on the following principles: prevention of infections, pain control, maintaining Oral function, the interplay with managing Oral complications of cancer treatment and improving quality of life. Using these fundamental elements, we developed a protocol to assist the health Care provider and present a practical approach for basic Oral Care. Research is warranted to provide robust scientific evidence and to enhance this clinical protocol.
-
basic Oral Care for hematology oncology patients and hematopoietic stem cell transplantation recipients a position paper from the joint task force of the multinational association of supportive Care in cancer international society of Oral oncology ma
Supportive Care in Cancer, 2015Co-Authors: Sharon Elad, Michael T Brennan, Judith E Raberdurlacher, Deborah P Saunders, Arno Mank, Yehuda Zadik, Barry Quinn, Joel B Epstein, N M A BlijlevensAbstract:Purpose Hematology–oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for Oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic Oral Care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the Oral complications, expert opinion is needed to shape the current optimal protocols.
Judith E Raberdurlacher - One of the best experts on this subject based on the ideXlab platform.
-
basic Oral Care for hematology oncology patients and hematopoietic stem cell transplantation recipients a position paper from the joint task force of the multinational association of supportive Care in cancer international society of Oral oncology ma
Supportive Care in Cancer, 2015Co-Authors: Sharon Elad, Michael T Brennan, Judith E Raberdurlacher, Deborah P Saunders, Arno Mank, Yehuda Zadik, Barry Quinn, Joel B EpsteinAbstract:Hematology–oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for Oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic Oral Care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the Oral complications, expert opinion is needed to shape the current optimal protocols. This position paper was developed by members of the Oral Care Study Group, Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT) in attempt to provide guidance to the health Care providers managing these patient populations. The protocol on basic Oral Care outlined in this position paper is presented based on the following principles: prevention of infections, pain control, maintaining Oral function, the interplay with managing Oral complications of cancer treatment and improving quality of life. Using these fundamental elements, we developed a protocol to assist the health Care provider and present a practical approach for basic Oral Care. Research is warranted to provide robust scientific evidence and to enhance this clinical protocol.
-
basic Oral Care for hematology oncology patients and hematopoietic stem cell transplantation recipients a position paper from the joint task force of the multinational association of supportive Care in cancer international society of Oral oncology ma
Supportive Care in Cancer, 2015Co-Authors: Sharon Elad, Michael T Brennan, Judith E Raberdurlacher, Deborah P Saunders, Arno Mank, Yehuda Zadik, Barry Quinn, Joel B Epstein, N M A BlijlevensAbstract:Purpose Hematology–oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for Oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic Oral Care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the Oral complications, expert opinion is needed to shape the current optimal protocols.